Author Relationships With Industry and Other Entities (Relevant) 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death (October 2017) Committee Member Employment Consultant Speakers Bureau Ownership/ Partnership/ Principal Personal Research Institutional, Organizational, or Other Financial Benefit Expert Witness Voting Recusals by Section* Sana M. Al-Khatib, Chair Duke Clinical Research Institute; Duke University Professor of Medicine None None None None None None None William G. Stevenson, Vice Chair Vanderbilt University Medical Center Professor; Brigham and Women s Hospital Director of Clinical Cardiac EP St. Jude Medical Boston Scientific Biosense Webster Michael J. Ackerman Mayo Clinic Professor of Medicine, Pediatrics, and Pharmacology; Long QT Syndrome/Genetic Heart Rhythm Clinic and the Mayo Clinic Windland Smith Rice Sudden Death Genomics Laboratory Director Audentes Therapeutics Boston Scientific Gilead Sciences Invitae Medtronic MyoKardia St. Jude Medical None None None Transgenomic (Familion) Blue Ox Health Corporation AliveCor StemoniX William J. Bryant Dominick Feld Hyde Attorney at Law None None None None None None None David J. Callans University of Pennsylvania Health System Professor of Medicine; Associate Director of EP Biosense Webster Biotronik Boston Scientific Medtronic St. Jude Medical None None Biosense Webster (PI) Endosense (PI) Anne B. Curtis University at Buffalo SUNY Distinguished Professor; Charles and Mary Bauer Professor and Chair Medtronic St. Jude Medical Barbara J. Deal Getz Professor of Cardiology Feinberg School of Medicine Northwestern University None None None None None None None Timm Dickfeld University of Maryland Associate Professor of Medicine Biosense St. Jude Medical Siemens None None Biosense General Electric Impulse Dynamics Siemens Anne M. Gillis University of Calgary Professor of Medicine None None None Christopher B. Granger Duke Clinical Research Institute; Duke University Professor of Medicine; Director, Cardiac Care Unit AstraZeneca Gilead Sciences GlaxoSmithKline Janssen Pharmaceuticals Medtronic Pfizer Sanofi-aventis None None AstraZeneca GlaxoSmithKline Janssen Pharmaceuticals Medtronic Pfizer Sanofi-aventis GE Healthcare Medtronic ZOLL Medical Spacelabs Phillips Stephen C. Hammill Mayo Clinic Professor Emeritus of Medicine None None None None None None None Mark A. Hlatky Stanford University School of Medicine Professor of Health and Research Policy, and of Cardiovascular Medicine None None None None None None None Jos A. Joglar UT Southwestern Medical Center Professor of Internal Medicine; Clinical Cardiac EP Fellowship Program Director None None None None None None None G. Neal Kay University of Alabama at Birmingham Professor Emeritus None None None None None None None Michael E. Field University of Wisconsin School of Medicine and Public Health Director, Clinical EP and Cardiac Arrhythmia Service, Associate Professor of Medicine None None None None None None None (Continued) CLINICAL STATEMENTS AND GUIDELINES Gregg C. Fonarow Ahmanson-UCLA Cardiomyopathy Center Director; UCLA Division of Cardiology Co-Chief Amgen Janssen Pharmaceuticals Medtronic ZS Pharma None None Medtronic IMPROVE-HF (Steering Committee) Medtronic Daniel D. Matlock University of Colorado School of Medicine Associate Professor of Medicine None None None None None None None Robert J. Myerburg University of Miami Miller School of Medicine Professor of Medicine and Physiology None None None None None None None Richard L. Page University of Wisconsin Hospital and Clinics Chair, Department of Medicine None None None None None None None This table represents the relationships of committee members with industry and other entities that were determined to be relevant to this document. 